Yoseph Shaaltiel

2015

In 2015, Yoseph Shaaltiel earned a total compensation of $653.5K as Executive Vice President, Research and Development at Protalix BioTherapeutics, a 16% decrease compared to previous year.

Compensation breakdown

Bonus$85,000
Option Awards$112,497
Salary$271,730
Stock Awards$110,244
Other$74,058
Total$653,529

Shaaltiel received $271.7K in salary, accounting for 42% of the total pay in 2015.

Shaaltiel also received $85K in bonus, $112.5K in option awards, $110.2K in stock awards and $74.1K in other compensation.

Rankings

In 2015, Yoseph Shaaltiel's compensation ranked 9,800th out of 13,638 executives tracked by ExecPay. In other words, Shaaltiel earned more than 28.1% of executives.

ClassificationRankingPercentile
All
9,800
out of 13,638
28th
Division
Manufacturing
3,737
out of 5,187
28th
Major group
Chemicals And Allied Products
1,370
out of 1,857
26th
Industry group
Drugs
1,122
out of 1,531
27th
Industry
Biological Products, Except Diagnostic Substances
196
out of 260
25th
Source: SEC filing on March 16, 2017.

Shaaltiel's colleagues

We found four more compensation records of executives who worked with Yoseph Shaaltiel at Protalix BioTherapeutics in 2015.

2015

Moshe Manor

Protalix BioTherapeutics

Chief Executive Officer

2015

Yossi Maimon

Protalix BioTherapeutics

Chief Financial Officer

2015

Einat Almon

Protalix BioTherapeutics

Senior Vice President, Product Development

2015

Tzvi Palash

Protalix BioTherapeutics

Chief Operating Officer

News

You may also like